Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansell

Showing results (261-270 of 2,414) with videos related to

Pageof 242
Sort By:
Journal of Thrombosis and Thrombolysis|July 4, 2014
Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolismSimon Mantha, Jack Ansell
The British Journal of Oral & Maxillofacial Surgery|January 19, 2016
Sphenopalatine block in the management of trigeminal neuralgiaGrant Isherwood, Mark Ansell
The Hand|February 1, 1975
A five-year follow-up of synovectomy of the proximal interphalangeal joint in rheumatoid arthritisB Ansell, S Harrison
FEBS Letters|November 24, 1999
The effect of iron limitation on glycerol production and expression of the isogenes for NAD(+)-dependent glycerol 3-phosphate dehydrogenase in Saccharomyces cerevisiaeR Ansell, L Adler
Current Drug Discovery Technologies|August 16, 2011
New targets for anticoagulation and future perspectivesJack Ansell, David Askin
AIDS Care|December 9, 2003
Enabling households to support successful migration of AIDS orphans in southern AfricaN Ansell, L Young
Drugs|January 27, 2005
Extended anticoagulation therapy for the primary and secondary prevention of venous thromboembolismElizabeth Blanchard, Jack Ansell
The Journal of Supportive Oncology|September 1, 2004
Management of thrombosis in the cancer patientNancy Andrea, Jack Ansell
Expert Opinion on Investigational Drugs|November 18, 2008
Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdictJennifer Carreiro, Jack Ansell
Leukemia Research|June 6, 2008
The use of cell lines for the study of Waldenström's macroglobulinemiaMorie Gertz, Stephen Ansell
Pageof 242

Showing results (261-270 of 2,414) with videos related to

Sort By:
Pageof 242
Journal of Thrombosis and Thrombolysis|July 4, 2014
Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolismSimon Mantha, Jack Ansell
The British Journal of Oral & Maxillofacial Surgery|January 19, 2016
Sphenopalatine block in the management of trigeminal neuralgiaGrant Isherwood, Mark Ansell
The Hand|February 1, 1975
A five-year follow-up of synovectomy of the proximal interphalangeal joint in rheumatoid arthritisB Ansell, S Harrison
FEBS Letters|November 24, 1999
The effect of iron limitation on glycerol production and expression of the isogenes for NAD(+)-dependent glycerol 3-phosphate dehydrogenase in Saccharomyces cerevisiaeR Ansell, L Adler
Current Drug Discovery Technologies|August 16, 2011
New targets for anticoagulation and future perspectivesJack Ansell, David Askin
AIDS Care|December 9, 2003
Enabling households to support successful migration of AIDS orphans in southern AfricaN Ansell, L Young
Drugs|January 27, 2005
Extended anticoagulation therapy for the primary and secondary prevention of venous thromboembolismElizabeth Blanchard, Jack Ansell
The Journal of Supportive Oncology|September 1, 2004
Management of thrombosis in the cancer patientNancy Andrea, Jack Ansell
Expert Opinion on Investigational Drugs|November 18, 2008
Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdictJennifer Carreiro, Jack Ansell
Leukemia Research|June 6, 2008
The use of cell lines for the study of Waldenström's macroglobulinemiaMorie Gertz, Stephen Ansell
Pageof 242